FDA inspection

Novartis Pharma Schweizerhalle Ag: FDA inspection ending Sep 25, 2012

FDA inspection 810431 · No Action Indicated (NAI) · Pratteln

Key facts

Inspection ID 810431
Firm Novartis Pharma Schweizerhalle Ag
FEI number 3002865753
Address Rothausstrasse 61
City Pratteln
Country Switzerland
Fiscal year 2012
Inspection end date Sep 25, 2012
Classification No Action Indicated (NAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections